PLoS Biology

Medications

Scientists say eye-disease drug may also help fight COVID

An interdisciplinary research team led by UCLA found that a drug already approved by the Food and Drug Administration for eye disease, verteporfin, stopped the replication of SARS-CoV-2, the virus that causes COVID-19. Their ...

Diseases, Conditions, Syndromes

Potential strategy to reduce fatigue after COVID-19 vaccination

Despite their strong effectiveness against SARS-CoV-2, mRNA-based COVID-19 vaccines are associated with adverse post-vaccination effects, such as fatigue; how can this be avoided? In a new study publishing May 31st in the ...

page 7 from 20